fluorodeoxyglucose f18 has been researched along with Esophagitis, Peptic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, HM; Lee, YC; Lin, JT; Tseng, PH; Tu, CH; Wang, HP; Wang, SY; Wu, MS; Wu, YW; Yang, WS | 1 |
| Alavi, A; Bural, GG; Kumar, R; Mavi, A | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Esophagitis, Peptic
| Article | Year |
|---|---|
Association of esophageal inflammation, obesity and gastroesophageal reflux disease: from FDG PET/CT perspective.
Topics: Adipose Tissue; Adult; Barrett Esophagus; Body Mass Index; Duodenum; Esophagitis, Peptic; Esophagoscopy; Esophagus; Female; Fluorodeoxyglucose F18; Gastric Mucosa; Gastroesophageal Reflux; Heartburn; Humans; Male; Middle Aged; Obesity; Positron-Emission Tomography; Severity of Illness Index; Stomach; Surveys and Questionnaires; Waist Circumference | 2014 |
Reflux esophagitis secondary to chemotherapy detected by serial FDG-PET.
Topics: Aged; Antineoplastic Agents; Colonic Neoplasms; Diagnosis, Differential; Diagnostic Errors; Esophageal Neoplasms; Esophagitis, Peptic; Esophagus; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |